UBS Group’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-22,500
Closed -$1.46M 9992
2024
Q3
$1.46M Buy
+22,500
New +$1.45M ﹤0.01% 4291
2020
Q4
Sell
-24,600
Closed -$2.13M 8434
2020
Q3
$2.13M Buy
+24,600
New +$2.05M ﹤0.01% 2984
2017
Q3
Sell
-10,000
Closed -$890K 7749
2017
Q2
$890K Hold
10,000
﹤0.01% 3718
2017
Q1
$898K Buy
+10,000
New +$862K ﹤0.01% 3622

Other funds holding CRI

UBS Group's CRI Position: Q2 2026 in Review

UBS Group reduced its Carter's (CRI) stake by 36% in Q2 2026, selling an estimated $14.5M and leaving 686,980 shares worth $28.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2321.

UBS Group first reported a position in CRI in Q4 2014 and has held it in 47 quarters since. The position peaked at $87.5M in Q4 2024. 287 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • UBS Group held 686,980 shares of Carter's worth $28.3M as of Q2 2026.
  • UBS Group sold 382,856 Carter's shares in Q2 2026, an estimated $14.5M.
  • Carter's made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2321 holding.
  • UBS Group first reported a position in Carter's in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Carter's position peaked at $87.5M in Q4 2024.
  • 287 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.